Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens

Patent metadata

Field	Value
Publication number	US-9586035-B2
Application number	US-33318208-A
Country	US
Kind code	B2
Filing date	Dec 11, 2008
Priority date	Dec 11, 2007
Publication date	Mar 7, 2017
Grant date	Mar 7, 2017

Abstract

An implantable medical device is provided for controlled drug delivery within the bladder, or other body vesicle. The device may include at least one drug reservoir component comprising a drug; and a vesicle retention frame which comprises an elastic wire having a first end, an opposing second end, and an intermediate region therebetween, wherein the drug reservoir component is attached to the intermediate region of the vesicle retention frame. The retention frame prevents accidental voiding of the device from the bladder, and it preferably has a spring constant selected for the device to effectively stay in the bladder during urination while minimizing the irritation of the bladder.

First claim

We claim:

1. An implantable medical device for controlled drug delivery comprising:
a drug reservoir portion comprising a drug; and
a retention frame portion attached to the drug reservoir portion, the retention framing portion comprising an elastic wire,
wherein the device is elastically deformable between a relatively straightened shape suited for insertion through a lumen into a body cavity of a patient and a coiled shape suited to retain the device within the body cavity, the elastic wire functioning as a spring to maintain the device in the coiled shape in the absence of a compressive load; and
wherein the elastic wire has a spring constant between 3 N/m and 60 N/m.

2. An implantable medical device for controlled drug delivery comprising:
at least one drug reservoir component which comprises
an elongated, water permeable, elastomeric tube having a first end and an opposing second end,
a solid or semi-solid drug formulation core within the tube, wherein the tube dispenses the drug in vivo at a controlled rate; and a retention frame which comprises an elastic wire which comprises a low modulus elastomer or a superelastic alloy,

wherein the elastomeric tube of the drug reservoir component is attached to the retention frame and is deformable along with the retention frame for implantation through a lumen into a body cavity of a patient, and the elastic wire is operable as a spring to maintain the device in a coiled shape in the absence of a compressive load; and
wherein the elastic wire has a spring constant between 3 N/m and 60 N/m.

Assignees

• Cima Michael J
• Lee Heejin
• Massachusetts Inst Technology

Inventors

• Cima Michael J
• Lee Heejin

Classifications

• A61P23/02

  Local anaesthetics · CPC title

• A61M31/00 Primary

  Devices for introducing or retaining media, e.g. remedies, in cavities of the body (A61M25/00 takes precedence {; introducing or retaining ophthalmic products into the ocular cavities A61F9/0008}) · CPC title

• A61F2250/0068

  the pharmaceutical product being in a reservoir · CPC title

• A61M2205/0216

  Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking · CPC title

• A61K31/167

  having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol · CPC title